Cite

HARVARD Citation

    Tekin, K. et al. (2018). Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study. Seminars in ophthalmology. pp. 265-270. [Online]. 
  
Back to record